FDA Inspection 1321584 — Department of Defense - Naval Hospital Camp Pendleton

Department of Defense - Naval Hospital Camp Pendleton — FEI 2076574

The FDA completed an inspection of Department of Defense - Naval Hospital Camp Pendleton on June 2, 2026 in Camp Pendleton, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 2, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Camp Pendleton, CA (United States)